Seminars in Oncology
Volume 32, Issue 2 , Pages 156-164 , April 2005

Palliative radiation therapy

  • Andre Konski

      Affiliations

    • Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA
    • Corresponding Author InformationAddress reprint requests to Andre Konski, MD, Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111
    • ,
  • Steven Feigenberg

      Affiliations

    • Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA
    • ,
  • Edward Chow

      Affiliations

    • Department of Radiation Oncology, Toronto-Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada

References 

  1. In:  Morris W editors. The American Heritage Dictionary of the English Language . Boston, MA: American Heritage; 1975;
  2. Body JJ . Metastatic bone disease (Clinical and therapeutic aspects) . Bone . 1992;13(suppl 1):S57–S62
  3. Tong D , Gillick L , Hendrickson FR . The palliation of symptomatic osseous metastases (Final results of the Study by the Radiation Therapy Oncology Group) . Cancer . 1982;50:893–899
  4. Blitzer PH . Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis . Cancer . 1985;55:1468–1472
  5. Cole DJ . A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases . Clin Oncol (R Coll Radiol) . 1989;1:59–62
  6. Madsen EL . Painful bone metastasis: Efficacy of radiotherapy assessed by the patients: A randomized trial comparing 4 Gy X 6 versus 10 Gy X 2 . Int J Radiat Oncol Biol Phys . 1983;9:1775–1779
  7. Hoskin PJ , Price P , Easton D , et al.   A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain . Radiother Oncol . 1992;23:74–78
  8. Niewald M , Tkocz HJ , Abel U , et al.   Rapid course radiation therapy vs. more standard treatment (A randomized trial for bone metastases) . Int J Radiat Oncol Biol Phys . 1996;36:1085–1089
  9. Price P , Hoskin PJ , Easton D , et al.   Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases . Radiother Oncol . 1986;6:247–255
  10. Rasmusson B , Vejborg I , Jensen AB , et al.   Irradiation of bone metastases in breast cancer patients (A randomized study with 1 year follow-up) . Radiother Oncol . 1995;34:179–184
  11. Nielsen OS , Bentzen SM , Sandberg E , et al.   Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases . Radiother Oncol . 1998;47:233–240
  12. Wu JS , Wong R , Johnston M , et al.   Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases . Int J Radiat Oncol Biol Phys . 2003;55:594–605
  13. van den Hout WB , van der Linden YM , Steenland E , et al.   Single- versus multiple-fraction radiotherapy in patients with painful bone metastases (Cost-utility analysis based on a randomized trial) . J Natl Cancer Inst . 2003;95:222–229
  14. Hartsell WF , Scott C , Bruner DW , et al.   Phase III randomized trial of 8 Gy in 1 fraction vs. 30 Gy in 10 fractions for palliation of painful bone metastases (Preliminary results of RTOG 97-14) . Int J Radiat Oncol Biol Phys . 2003;57(suppl):S124; (abstr)
  15. Salazar OM , Rubin P , Hendrickson FR , et al.   Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors (Final Radiation Therapy Oncology Group report) . Cancer . 1986;58:29–36
  16. Poulter CA , Cosmatos D , Rubin P , et al.   A report of RTOG 8206 (A phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases) . Int J Radiat Oncol Biol Phys . 1992;23:207–214
  17. Scarantino CW , Caplan R , Rotman M , et al.   A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases—RTOG 88-22 . Int J Radiat Oncol Biol Phys . 1996;36:37–48
  18. Perez CA , Cosmatos D , Garcia DM , et al.   Irradiation in relapsing carcinoma of the prostate . Cancer . 1993;71(suppl):1110–1122
  19. Zelefsky MJ , Scher HI , Forman JD , et al.   Palliative hemiskeletal irradiation for widespread metastatic prostate cancer (A comparison of single dose and fractionated regimens) . Int J Radiat Oncol Biol Phys . 1989;17:1281–1285
  20. Mortimer JE , Taylor ME . Positron emitting 18F-2-deoxy-2-fluoro-D-glucose (Potential hot new therapy) . Breast Cancer Res . 2003;5:329–331
  21. Firusian N , Mellin P , Schmidt CG . Results of 89 strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases (A preliminary report) . J Urol . 1976;116:764–768
  22. Buchali K , Correns HJ , Schuerer M , et al.   Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma . Eur J Nucl Med . 1988;14:349–351
  23. Quilty PM , Kirk D , Bolger JJ , et al.   A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer . Radiother Oncol . 1994;31:33–40
  24. Reddy EK , Robinson RG , Mansfield CM . Strontium 89 for palliation of bone metastases . J Natl Med Assoc . 1986;78:27–32
  25. Porter AT , Forman JD . The use of systemic radionuclides in the treatment of metastatic bone disease . In:  Mauch PM ,  Loeffler JS editor. Radiation Oncology (Technology and Biology) . Philadelphia, PA: Saunders; 1994;p. 381–386
  26. Porter AT , McEwan AJ , Powe JE , et al.   Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer . Int J Radiat Oncol Biol Phys . 1993;25:805–813
  27. Oosterhof GO , Roberts JT , de Reijke TM , et al.   Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer (A phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group) . Eur Urol . 2003;44:519–526
  28. Smeland S , Erikstein B , Aas M , et al.   Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable (Results of a double-blind randomized study) . Int J Radiat Oncol Biol Phys . 2003;56:1397–1404
  29. Serafini AN , Houston SJ , Resche I , et al.   Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam (A double-blind placebo-controlled clinical trial) . J Clin Oncol . 1998;16:1574–1581
  30. Resche I , Chatal JF , Pecking A , et al.   A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases . Eur J Cancer . 1997;33:1583–1591
  31. Wang RF , Zhang CL , Zhu SL , et al.   A comparative study of samarium-153-ethylenediaminetetramethylene phosphonic acid with pamidronate disodium in the treatment of patients with painful metastatic bone cancer . Med Princ Pract . 2003;12:97–101
  32. Gaspar LE , Scott C , Murray K , et al.   Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases . Int J Radiat Oncol Biol Phys . 2000;47:1001–1006
  33. Gaspar L , Scott C , Rotman M , et al.   Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials . Int J Radiat Oncol Biol Phys . 1997;37:745–751
  34. Nieder C , Nestle U , Motaref B , et al.   Prognostic factors in brain metastases (Should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?) . Int J Radiat Oncol Biol Phys . 2000;46:297–302
  35. Agboola O , Benoit B , Cross P , et al.   Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases . Int J Radiat Oncol Biol Phys . 1998;42:155–159
  36. Buchsbaum JC , Suh JH , Lee SY , et al.   Survival by Radiation Therapy Oncology Group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma (A retrospective study) . Cancer . 2002;94:2265–2272
  37. Lutterbach J , Bartelt S , Stancu E , et al.   Patients with brain metastases (Hope for recursive partitioning analysis (RPA) class 3) . Radiother Oncol . 2002;63:339–345
  38. Borgelt B , Gelber R , Kramer S , et al.   The palliation of brain metastases (final results of the first two studies by the Radiation Therapy Oncology Group) . Int J Radiat Oncol Biol Phys . 1980;6:1–9
  39. Borgelt B , Gelber R , Larson M , et al.   Ultra-rapid high dose irradiation schedules for the palliation of brain metastases (Final results of the first two studies by the Radiation Therapy Oncology Group) . Int J Radiat Oncol Biol Phys . 1981;7:1633–1638
  40. Murray KJ , Scott C , Greenberg HM , et al.   A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases (A report of the Radiation Therapy Oncology Group (RTOG) 9104) . Int J Radiat Oncol Biol Phys . 1997;39:571–574
  41. Sanghavi SN , Miranpuri SS , Chappell R , et al.   Radiosurgery for patients with brain metastases (A multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method) . Int J Radiat Oncol Biol Phys . 2001;51:426–434
  42. Williams J , Enger C , Wharam M , et al.   Stereotactic radiosurgery for brain metastases (Comparison of lung carcinoma vs) . non-lung tumors. J Neurooncol . 1998;37:79–85
  43. Nakagawa K , Tago M , Terahara A , et al.   A single institutional outcome analysis of Gamma Knife radiosurgery for single or multiple brain metastases . Clin Neurol Neurosurg . 2000;102:227–232
  44. Sperduto PW . A review of stereotactic radiosurgery in the management of brain metastases . Technol Cancer Res Treat . 2003;2:105–110
  45. Manning MA , Cardinale RM , Benedict SH , et al.   Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases . Int J Radiat Oncol Biol Phys . 2000;47:603–608
  46. Sperduto PW , Scott C , Andrews D , et al.   Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases (Report of Radiation Therapy Oncology Group phase III study 95-08) . Int J Radiat Oncol Biol Phys . 2002;54:3
  47. Mehta MP , Shapiro WR , Glantz MJ , et al.   Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases (centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points) . J Clin Oncol . 2002;20:3445–3453
  48. Packer RJ . Radiation-induced neurocognitive decline (the risks and benefits of reducing the amount of whole-brain irradiation) . Curr Neurol Neurosci Rep . 2002;2:131–133
  49. Regine WF , Scott C , Murray K , et al.   Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy (An analysis from Radiation Therapy Oncology Group Study 91-04) . Int J Radiat Oncol Biol Phys . 2001;51:711–717
  50. Abayomi OK . Pathogenesis of irradiation-induced cognitive dysfunction . Acta Oncol . 1996;35:659–663
  51. Armstrong CL , Corn BW , Ruffer JE , et al.   Radiotherapeutic effects on brain function (double dissociation of memory systems) . Neuropsychiatry Neuropsychol Behav Neurol . 2000;13:101–111
  52. Regine WF , Huhn JL , Patchell RA , et al.   Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases (Results and implications) . Int J Radiat Oncol Biol Phys . 2002;52:333–338
  53. Sneed PK , Suh JH , Goetsch SJ , et al.   A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases . Int J Radiat Oncol Biol Phys . 2002;53:519–526
  54. Rades D , Karstens JH , Alberti W . Role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression (Comparison of three different fractionation schedules) . Int J Radiat Oncol Biol Phys . 2002;54:1160–1164
  55. Rades D , Karstens JH . A comparison of two different radiation schedules for metastatic spinal cord compression considering a new prognostic factor . Strahlenther Onkol . 2002;178:556–561
  56. Maranzano E , Trippa F , Chirico L , et al.   Management of metastatic spinal cord compression . Tumori . 2003;89:469–475
  57. Hoskin PJ , Grover A , Bhana R . Metastatic spinal cord compression (Radiotherapy outcome and dose fractionation) . Radiother Oncol . 2003;68:175–180
  58. Regine WF , Tibbs PA , Young A , et al.   Metastatic spinal cord compression (A randomized trial of direct decompressive surgical resection plus radiotherapy vs. radiotherapy alone) . Int J Radiat Oncol Biol Phys . 2003;57(suppl):S125; (abstr)
  59. Grosu AL , Andratschke N , Nieder C , et al.   Retreatment of the spinal cord with palliative radiotherapy . Int J Radiat Oncol Biol Phys . 2002;52:1288–1292
  60. Lutz ST , Huang DT , Ferguson CL , et al.   A retrospective quality of life analysis using the Lung Cancer Symptom Scale in patients treated with palliative radiotherapy for advanced nonsmall cell lung cancer . Int J Radiat Oncol Biol Phys . 1997;37:117–122
  61. Bezjak A , Dixon P , Brundage M , et al.   Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15) . Int J Radiat Oncol Biol Phys . 2002;54:719–728
  62. Simpson JR , Francis ME , Perez-Tamayo R , et al.   Palliative radiotherapy for inoperable carcinoma of the lung (Final report of a RTOG multi-institutional trial) . Int J Radiat Oncol Biol Phys . 1985;11:751–758
  63. Inoperable non-small cell lung cancer (NSCLC); a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer 63:265-270, 1991
  64. Abratt RP , Bogart JA , Hunter A . Hypofractionated irradiation for non-small cell lung cancer . Lung Cancer . 2002;36:225–233
  65. Cross CK , Berman S , Buswell L , et al.   A prospective study of palliative hypofractionated radiation therapy (8.5 Gy × 2) for patients with symptomatic non-small cell lung cancer . Int J Radiat Oncol Biol Phys . 2003;57(suppl):S279–S280
  66. Raju PI , Roy T , McDonald RD , et al.   IR-192, low dose rate endobronchial brachytherapy in the treatment of malignant airway obstruction . Int J Radiat Oncol Biol Phys . 1993;27:677–680
  67. Macha HN , Wahlers B , Reichle C , et al.   Endobronchial radiation therapy for obstructing malignancies (Ten years’ experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients) . Lung . 1995;173:271–280
  68. Chang LF , Horvath J , Peyton W , et al.   High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer . Int J Radiat Oncol Biol Phys . 1994;28:589–596
  69. Lo TC , Girshovich L , Healey GA , et al.   Low dose rate versus high dose rate intraluminal brachytherapy for malignant endobronchial tumors . Radiother Oncol . 1995;35:193–197
  70. Mehta M , Petereit D , Chosy L , et al.   Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway occlusion . Int J Radiat Oncol Biol Phys . 1992;23:133–139
  71. Nag S , Kelly JF , Horton JL , et al.   Brachytherapy for carcinoma of the lung . Oncology (Huntingt) . 2001;15:371–381
  72. Suh JH , Dass KK , Pagliaccio L , et al.   Endobronchial radiation therapy with or without neodymium yttrium aluminum garnet laser resection for managing malignant airway obstruction . Cancer . 1994;73:2583–2588
  73. Allen MD , Baldwin JC , Fish VJ , et al.   Combined laser therapy and endobronchial radiotherapy for unresectable lung carcinoma with bronchial obstruction . Am J Surg . 1985;150:71–77
  74. Frenken M . Best palliation in esophageal cancer (Surgery, stenting, radiation, or what?) . Dis Esophagus . 2001;14:120–123
  75. Sharma V , Mahantshetty U , Dinshaw KA , et al.   Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy . Int J Radiat Oncol Biol Phys . 2002;52:310–315
  76. Konigsrainer A , Riedmann B , De Vries A , et al.   Expandable metal stents versus laser combined with radiotherapy for palliation of unresectable esophageal cancer (A prospective randomized trial) . Hepatogastroenterology . 2000;47:724–727
  77. Sur RK , Levin CV , Donde B , et al.   Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma—An International Atomic Energy Agency study . Int J Radiat Oncol Biol Phys . 2002;53:127–133
  78. Bialas B , Rutkowski T , Fijalkowski M , et al.   Influence of previous treatment on palliative effect of HDR brachytherapy in advanced esophageal cancer . Neoplasma . 2000;47:187–190
  79. Kinsman KJ , DeGregorio BT , Katon RM , et al.   Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy . Gastrointest Endosc . 1996;43:196–203
  80. Yakami M , Mitsumori M , Sai H , et al.   Development of severe complications caused by stent placement followed by definitive radiation therapy for T4 esophageal cancer . Int J Clin Oncol . 2003;8:395–398
  81. Siersema PD , Hop WC , Dees J , et al.   Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy (A controlled, prospective study) . Gastrointest Endosc . 1998;47:113–120
  82. Abe T , Tangoku A , Hayashi H , et al.   Esophageal perforation and mediastinal abscess following placement of a covered self-expanding metallic stent and radiation therapy in a cancer patient . Surg Endosc . 1999;13:1044–1046
  83. Janjan NA , Breslin T , Lenzi R , et al.   Avoidance of colostomy placement in advanced colorectal cancer with twice weekly hypofractionated radiation plus continuous infusion 5-fluorouracil . J Pain Symptom Manage . 2000;20:266–272
  84. Wong R , Thomas G , Cummings B , et al.   The role of radiotherapy in the management of pelvic recurrence of rectal cancer . Can J Oncol . 1996;6(suppl 1):39–47
  85. Hayashi M , Shirai Y , Hatakeyama K . Complete remission after radiotherapy for recurrent rectal cancer . Hepatogastroenterology . 1997;44:1612–1613
  86. Begum N , Asghar AH , et al.   High dose rate intraluminal brachytherapy in combination with external beam radiotherapy for palliative treatment of cancer rectum . N S J Coll Physicians Surg Pak . 2003;13:633–636
  87. Mischinger HJ , Hauser H , Cerwenka H , et al.   Endocavitary Ir-192 radiation and laser treatment for palliation of obstructive rectal cancer . Eur J Surg Oncol . 1997;23:428–431
  88. Conio M , Picasso M , Orsatti M , et al.   Combined treatment with lasertherapy (Nd:YAG) and endocavitary radiation in the palliation of rectal cancer . Hepatogastroenterology . 1996;43:1518–1522
  89. Mohiuddin M , Chen E , Ahmad N . Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer . J Clin Oncol . 1996;14:722–728
  90. Dawson LA , McGinn CJ , Lawrence TS . Conformal chemoradiation for primary and metastatic liver malignancies . Semin Surg Oncol . 2003;21:249–255
  91. Malik U , Mohiuddin M . External-beam radiotherapy in the management of liver metastases . Semin Oncol . 2002;29:196–201
  92. Dawson LA , Normolle D , Balter JM , et al.   Analysis of radiation-induced liver disease using the Lyman NTCP model . Int J Radiat Oncol Biol Phys . 2002;53:810–821
  93. Herfarth KK , Debus J , Lohr F , et al.   Stereotactic single-dose radiation therapy of liver tumors (Results of a phase I/II trial) . J Clin Oncol . 2001;19:164–170
  94. Herfarth KK , Debus J , Lohr F , et al.   Extracranial stereotactic radiation therapy (Set-up accuracy of patients treated for liver metastases) . Int J Radiat Oncol Biol Phys . 2000;46:329–335
  95. Timmerman R , Papiez L , Suntharalingam M . Extracranial stereotactic radiation delivery (Expansion of technology beyond the brain) . Technol Cancer Res Treat . 2003;2:153–160
  96. Lo SS , Wu CW , Chi KH , et al.   Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma . Cancer . 2000;89:29–34
  97. Montemaggi P , Morganti AG , Dobelbower RR , et al.   Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers (Is it just for palliation?) . Radiology . 1996;199:861–866
  98. Ampil FL . Radiation therapy palliation in malignancy-associated ureteral obstruction . Radiat Med . 1989;7:282–286
  99. Kynaston HG , Keen CW , Matthews PN . Radiotherapy for palliation of locally advanced prostatic carcinoma . Br J Urol . 1990;66:515–517
  100. Kawakami S, Kawai T, Yonese J, et al: [Palliative radiotherapy for local progression of hormone refractory stage D2 prostate cancer]. Nippon Hinyokika Gakkai Zasshi 84:1681–1684, 1993
  101. Kalapurakal JA , Pierce M , Chen A , et al.   Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer (A preliminary report) . Int J Radiat Oncol Biol Phys . 2003;57:654–664
  102. McLaren DB , Morrey D , Mason MD . Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly . Radiother Oncol . 1997;43:171–174
  103. Scholten AN , Leer JW , Collins CD , et al.   Hypofractionated radiotherapy for invasive bladder cancer . Radiother Oncol . 1997;43:163–169
  104. Smith SC , Koh WJ . Palliative radiation therapy for gynaecological malignancies . Best Pract Res Clin Obstet Gynaecol . 2001;15:265–278
  105. Firat S , Erickson B . Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum . Gynecol Oncol . 2001;80:213–220
  106. Halle JS , Rosenman JG , Varia MA , et al.   1000 cGy single dose palliation for advanced carcinoma of the cervix or endometrium . Int J Radiat Oncol Biol Phys . 1986;12:1947–1950
  107. Onsrud M , Hagen B , Strickert T . 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri . Gynecol Oncol . 2001;82:167–171
  108. Adelson MD , Wharton JT , Delclos L , et al.   Palliative radiotherapy for ovarian cancer . Int J Radiat Oncol Biol Phys . 1987;13:17–21
  109. Tan HS . Use of high dose rate gammamed brachytherapy in the palliative treatment of gynaecological cancer . Ann Acad Med Singapore . 1994;23:231–234
  110. Bjordal K , Kaasa S , Mastekaasa A . Quality of life in patients treated for head and neck cancer (A follow-up study 7 to 11 years after radiotherapy) . Int J Radiat Oncol Biol Phys . 1994;28:847–856
  111. Weissberg JB , Pillsbury H , Sasaki CT , et al.   High fractional dose irradiation of advanced head and neck cancer (Implications for combined radiotherapy and surgery) . Arch Otolaryngol . 1983;109:98–102
  112. Hodson DI , Bruera E , Eapen L , et al.   The role of palliative radiotherapy in advanced head and neck cancer . Can J Oncol . 1996;6(suppl 1):54–60
  113. Haraf DJ , Weichselbaum RR , Vokes EE . Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer (A potentially curable disease) . Ann Oncol . 1996;7:913–918
  114. Eisbruch A , Dawson L . Re-irradiation of head and neck tumors (Benefits and toxicities) . Hematol Oncol Clin North Am . 1999;13:825–836
  115. Kao J , Garofalo MC , Milano MT , et al.   Reirradiation of recurrent and second primary head and neck malignancies (A comprehensive review) . Cancer Treat Rev . 2003;29:21–30
  116. Paulino AC , Reddy SP . Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders . Am J Hosp Palliat Care . 1996;13:32–35
  117. Raju PI , Roy T , Knight W , et al.   Palliative radiation therapy for Kaposi’s sarcoma in patients with AIDS . Mo Med . 1990;87:26–28
  118. de Wit R , Smit WG , Veenhof KH , et al.   Palliative radiation therapy for AIDS-associated Kaposi’s sarcoma by using a single fraction of 800 cGy . Radiother Oncol . 1990;19:131–136
  119. Maor M , Chan RC , Young SE . Radiotherapy of choroidal metastases (Breast cancer as primary site) . Cancer . 1977;40:2081–2086
  120. Minatel E , Trovo MG , Forner L , et al.   The efficacy of radiotherapy in the treatment of intraocular metastases . Br J Radiol . 1993;66:699–702
  121. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain. Randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 52:111–121, 1999
  122. Okawa T , Kita M , Goto M , et al.   Randomized prospective clinical study of small, large and twice-a-day fraction radiotherapy for painful bone metastases . Radiother Oncol . 1988;13:99–104
  123. Steenland E , Leer JW , van Houwelingen H , et al.   The effect of a single fraction compared to multiple fractions on painful bone metastases (A global analysis of the Dutch Bone Metastasis Study) . Radiother Oncol . 1999;52:101–109

PII: S0093-7754(04)00570-6

doi: 10.1053/j.seminoncol.2004.11.013

Seminars in Oncology
Volume 32, Issue 2 , Pages 156-164 , April 2005

Article Tools